Is There a Role for Maintenance PARP for Patients With Platinum-Sensitive Ovarian Cancer?
Drs. Sarah W. Gordon, Sarah M. Temkin, Debra L. Richardson, and Kathleen Moore debate the role of maintenance PARP in platinum-sensitive ovarian cancer.
FEATURED BLOGS
May 25, 2018
Dr. Jane Lowe Meisel shares a first look at the program for the Women's Networking Center at the 2018 ASCO Annual Meeting.
May 25, 2018
Dr. Edward S. Kim encourages you to register today and join the Research Community Forum in September for 2 days of learning and collaboration.
May 24, 2018
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab...
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
May 23, 2018
IDEA and LIFe recipient Dr. Susmita Sharma is working hard during her U.S. fellowship so that she can achieve her dream of delivering exceptional cancer care to her patients in Nepal.
May 23, 2018
I thought providing good care was enough. I thought treating everyone the same was enough. But I realized that I have to be aware of how race and racism affect my patients and how they experience the...
May 22, 2018
Sometimes cross-coverage means having hard conversations with patients who aren't ours, but who still deserve our expertise and our honesty.
Advertisement
2018 ASCO Annual Meeting: Delivering Discoveries, Expanding the Reach of Precision Medicine
Latest Comments & Discussions
May 17, 2018
A 22 year old male with the diagnosis of Hodgkin lymphoma, classic type advanced stage admitted to the oncology clinic.
He has...
Most Read
The Lebanese Breast Cancer Foundation hosts an annual event with mothers and daughters to raise both health awareness and funds to support patients with breast cancer who need financial assistance.
For those not in our field, cancer is still seen as a devastating disease starting at the point of diagnosis. As oncology professionals, it’s important that we do not accept death from cancer as inevitable, or even as imminent.
As scientistics, we know that data matters. Dr. Reshma Jagsi and I examine the data about gender and participation in the ASCO Annual Meeting.
Attending the premier cancer conference for the first time and don't know where to start? Check out these tips.
Join us June 1-5 in Chicago for science, education, and networking.
Abdolali Shahrasbi, MD